NYSE · Healthcare · Drug Manufacturers - General
Price at previous close. Open the live page for real-time data.
| Market cap | $149.38B |
| P/E ratio | 19.91204245094113 |
| P/B ratio | 1.6554878414224035 |
| P/S ratio | 2.359351218510622 |
| Dividend yield | 6.56% |
| Return on equity | — |
| Net margin | 11.8% |
| EPS (TTM) | — |
| Beta | 0.295 |
| 52-week range | $23.11 – $28.75 |
Pfizer Inc. is a global biopharmaceutical leader engaged in the research, development, production, marketing, and distribution of a wide array of medicinal and vaccine products worldwide. Its comprehensive portfolio addresses diverse therapeutic areas, including cardiovascular health and women's health, featuring key brands such as the Premarin family and Eliquis. The company also offers advanced biologics, small molecule drugs, immunotherapies, and biosimilars for various conditions, exemplified by Ibrance, Xtandi, and Retacrit. Furthermore, Pfizer provides sterile injectables, anti-infective agents, and a significant oral treatment for COVID-19, including Paxlovid. A substantial portion of its offerings comprises vaccines for infectious diseases such as pneumococcal and meningococcal disease, tick-borne encephalitis, and COVID-19, with notable products like Comirnaty and the Prevnar fa…
What is Pfizer Inc.'s P/E ratio?
Pfizer Inc.'s trailing price-to-earnings (P/E) ratio is 19.9.
Does Pfizer Inc. pay a dividend?
Yes — the trailing dividend yield is approximately 6.56%.
What is PFE's market capitalisation?
Pfizer Inc.'s market cap is approximately $149.38B.
Educational data only — not financial advice. Figures from Financial Modeling Prep, updated periodically. Verify before acting.